Talkspace (TALK) Competitors $2.80 +0.08 (+2.94%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.77 -0.03 (-1.07%) As of 08/22/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TALK vs. NHC, VRDN, AVAH, TDOC, AHCO, OMDA, GRAL, PNTG, FTRE, and FLGTShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include National HealthCare (NHC), Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), Teladoc Health (TDOC), AdaptHealth (AHCO), Omada Health (OMDA), GRAIL (GRAL), The Pennant Group (PNTG), Fortrea (FTRE), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. Talkspace vs. Its Competitors National HealthCare Viridian Therapeutics Aveanna Healthcare Teladoc Health AdaptHealth Omada Health GRAIL The Pennant Group Fortrea Fulgent Genetics National HealthCare (NYSE:NHC) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends. Do analysts recommend NHC or TALK? Talkspace has a consensus target price of $4.50, suggesting a potential upside of 60.71%. Given Talkspace's stronger consensus rating and higher probable upside, analysts clearly believe Talkspace is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in NHC or TALK? 56.4% of National HealthCare shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 15.0% of National HealthCare shares are held by company insiders. Comparatively, 23.5% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, NHC or TALK? National HealthCare has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500. Is NHC or TALK more profitable? National HealthCare has a net margin of 10.03% compared to Talkspace's net margin of 1.41%. National HealthCare's return on equity of 6.87% beat Talkspace's return on equity.Company Net Margins Return on Equity Return on Assets National HealthCare10.03% 6.87% 4.68% Talkspace 1.41%2.48%2.11% Which has higher valuation & earnings, NHC or TALK? National HealthCare has higher revenue and earnings than Talkspace. National HealthCare is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational HealthCare$1.46B1.22$66.80M$6.7117.11Talkspace$202.61M2.31$1.15M$0.02140.00 Does the media favor NHC or TALK? In the previous week, National HealthCare and National HealthCare both had 3 articles in the media. National HealthCare's average media sentiment score of 0.79 beat Talkspace's score of 0.41 indicating that National HealthCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National HealthCare 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Talkspace 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryTalkspace beats National HealthCare on 9 of the 16 factors compared between the two stocks. Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$455.51M$2.08B$5.76B$9.58BDividend YieldN/AN/A4.41%4.10%P/E Ratio140.0738.6631.1026.04Price / Sales2.3110.17433.45102.77Price / Cash228.9351.9937.7358.48Price / Book4.186.709.536.61Net Income$1.15M-$63.67M$3.26B$265.56M7 Day Performance9.37%4.61%2.10%1.97%1 Month Performance6.87%0.23%2.81%-0.36%1 Year Performance58.19%26.48%30.56%19.03% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace3.7872 of 5 stars$2.80+2.9%$4.50+60.7%+64.7%$455.51M$202.61M140.07500NHCNational HealthCareN/A$107.76+0.2%N/A-11.8%$1.67B$1.46B13.5012,400News CoverageVRDNViridian Therapeutics1.6214 of 5 stars$18.11-2.3%$37.00+104.3%+25.4%$1.51B$300K-4.7350AVAHAveanna Healthcare1.9329 of 5 stars$7.04-0.6%$6.45-8.4%+37.8%$1.48B$2.02B88.0033,500News CoverageAnalyst UpgradeTDOCTeladoc Health3.0632 of 5 stars$7.48-0.5%$9.76+30.5%+8.0%$1.33B$2.57B-6.295,500Positive NewsAHCOAdaptHealth4.3501 of 5 stars$9.38-1.1%$13.40+42.9%-4.8%$1.28B$3.26B17.3710,500News CoveragePositive NewsOMDAOmada HealthN/A$20.91+1.9%$24.57+17.5%N/A$1.18BN/A0.00849News CoveragePositive NewsGRALGRAIL1.0223 of 5 stars$32.80+1.1%$31.50-4.0%+107.0%$1.17B$125.60M-2.501,360Insider TradePNTGThe Pennant Group3.8371 of 5 stars$25.11-0.6%$33.40+33.0%-24.2%$873.04M$695.24M32.197,000FTREFortrea3.8576 of 5 stars$7.92-1.5%$13.30+67.9%-61.0%$730.03M$2.70B-0.7015,500FLGTFulgent Genetics3.6985 of 5 stars$21.52+1.2%$25.33+17.7%-5.6%$650.75M$283.47M-12.961,313Positive News Related Companies and Tools Related Companies National HealthCare Competitors Viridian Therapeutics Competitors Aveanna Healthcare Competitors Teladoc Health Competitors AdaptHealth Competitors Omada Health Competitors GRAIL Competitors The Pennant Group Competitors Fortrea Competitors Fulgent Genetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TALK) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access